{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T16:16:04Z","timestamp":1769876164509,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003035","name":"Aase and Ejnar Danielsens Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003035","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Timber Merchant Vilhelm Bangs Foundation"},{"DOI":"10.13039\/501100007438","name":"The Hede-Nielsen Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Danish Council for Independent Research, Medical Sciences (FSS)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.diabres.2011.12.008","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T20:29:31Z","timestamp":1325363371000},"page":"84-89","source":"Crossref","is-referenced-by-count":28,"title":["High YKL-40 levels predict mortality in patients with type 2 diabetes"],"prefix":"10.1016","volume":"96","author":[{"given":"Frederik","family":"Persson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla Noelle","family":"Rathcke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari-Anne","family":"Gall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Henrik","family":"Parving","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.diabres.2011.12.008_bib0005","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2217\/fon.09.66","article-title":"Plasma YKL-40: a potential new cancer biomarker?","volume":"5","author":"Johansen","year":"2009","journal-title":"Future Oncol"},{"issue":"2","key":"10.1016\/j.diabres.2011.12.008_bib0010","first-page":"172","article-title":"Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer","volume":"53","author":"Johansen","year":"2006","journal-title":"Dan Med Bull"},{"issue":"20","key":"10.1016\/j.diabres.2011.12.008_bib0015","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa073600","article-title":"A chitinase-like protein in the lung and circulation of patients with severe asthma","volume":"357","author":"Chupp","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.diabres.2011.12.008_bib0020","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCA.0b013e328241d991","article-title":"Serum YKL-40 levels in patients with coronary artery disease","volume":"18","author":"Kucur","year":"2007","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.diabres.2011.12.008_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2840-8-61","article-title":"YKL-40\u2014an emerging biomarker in cardiovascular disease and diabetes","volume":"8","author":"Rathcke","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.diabres.2011.12.008_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00011-005-0010-8","article-title":"YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance","volume":"55","author":"Rathcke","year":"2006","journal-title":"Inflamm Res"},{"issue":"2","key":"10.1016\/j.diabres.2011.12.008_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/dc08-1144","article-title":"YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria","volume":"32","author":"Rathcke","year":"2009","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2011.12.008_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.diabres.2011.12.008_bib0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2010.02.035","article-title":"Increased YKL-40 expression in patients with carotid atherosclerosis","volume":"211","author":"Michelsen","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.diabres.2011.12.008_bib0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.diabres.2011.12.008_bib0055","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.107.720847","article-title":"Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people","volume":"117","author":"Schramm","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.diabres.2011.12.008_bib0060","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.diabres.2011.12.008_bib0065","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/ndt\/gfr009","article-title":"Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate","volume":"26","author":"Reinhard","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2011.12.008_bib0070","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/diab.44.11.1303","article-title":"Albuminuria and poor glycemic control predicts mortality in NIDDM","volume":"44","author":"Gall","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2011.12.008_bib0075","first-page":"645","article-title":"The diagnosis of ischaemic heart pain and intermittent claudication in field surveys","volume":"27","author":"Rose","year":"1962","journal-title":"Bull WHO"},{"key":"10.1016\/j.diabres.2011.12.008_bib0080","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1161\/01.CIR.21.6.1160","article-title":"The electrocardiogram in population studies: a classification system","volume":"21","author":"Blackburn","year":"1960","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2011.12.008_bib0085","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF00400995","article-title":"Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients","volume":"34","author":"Gall","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2011.12.008_bib0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-4347(00)81481-4","article-title":"Quantitative determination of hemoglobin A1c by thinlayer isoelectric focusing","volume":"182","author":"Mortensen","year":"1980","journal-title":"J Chromatogr"},{"issue":"6","key":"10.1016\/j.diabres.2011.12.008_bib0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.diabres.2011.12.008_bib0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2362.2010.02446.x","article-title":"YKL-40 in type 2 diabetic patients with different levels of albuminuria","volume":"41","author":"Brix","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diabres.2011.12.008_bib0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2840-10-54","article-title":"YKL-40 levels are independently associated with albuminuria in type 2 diabetes","volume":"10","author":"Rondbjerg","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"10.1016\/j.diabres.2011.12.008_bib0110","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.2337\/db08-0182","article-title":"Plasma YKL-40 A BMI-Independent Marker of Type 2 Diabetes","volume":"57","author":"Nielsen","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2011.12.008_bib0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00011-006-0076-y","article-title":"YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis","volume":"55","author":"Rathcke","year":"2006","journal-title":"Inflamm Res"},{"issue":"2","key":"10.1016\/j.diabres.2011.12.008_bib0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/14017430903402218","article-title":"Plasma YKL-40 levels are elevated in patients with chronic heart failure","volume":"44","author":"Rathcke","year":"2010","journal-title":"Scand Cardiovasc J"},{"issue":"50","key":"10.1016\/j.diabres.2011.12.008_bib0125","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/onc.2009.292","article-title":"YKL-40, a secreted glycoprotein, promotes tumor angiogenesis","volume":"28","author":"Shao","year":"2009","journal-title":"Oncogene"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822711006760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822711006760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T10:26:38Z","timestamp":1543314398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822711006760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0168822711006760"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2011.12.008","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}